RBC
PGEN icon

Ronald Blue & Co’s Precigen PGEN Stock Holding History

Ronald Blue & Co’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$468K Hold
19,423
– – 0.02% 126
2017
Q1 		$385K Sell
19,423
-175
-0.9% -$3.91K 0.01% 131
2016
Q4 		$472K Buy
+19,598
New +$546K 0.02% 116

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Ronald Blue & Co's PGEN Position: Q2 2017 in Review

Ronald Blue & Co held its Precigen (PGEN) position steady in Q2 2017 at 19,423 shares worth $468K. The position accounts for 0.02% of the portfolio, ranked #126.

Ronald Blue & Co first reported a position in PGEN in Q4 2016 and has held it in 3 quarters since. The position peaked at $472K in Q4 2016. 172 funds tracked by Wall St. Rank hold PGEN as of Q2 2017.

  • Ronald Blue & Co held 19,423 shares of Precigen worth $468K as of Q2 2017.
  • Ronald Blue & Co left its Precigen share count unchanged in Q2 2017.
  • Precigen made up 0.02% of Ronald Blue & Co's portfolio in Q2 2017, its #126 holding.
  • Ronald Blue & Co first reported a position in Precigen in Q4 2016 and has held it in 3 quarters since.
  • Ronald Blue & Co's Precigen position peaked at $472K in Q4 2016.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.